Compare Stocks

→ The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
APHA Aphria	$15.38	$15.48	$2.78 ▼ $32.29	$4.87B	2.67	21.83 million shs	N/A
CRON Cronos Group	$2.88 +1.1%	$2.44	$1.64 ▼ $2.99	$1.10B	1.11	3.01 million shs	63,370 shs
STDAF STADA Arzneimittel Aktiengesellschaft	$110.42	$110.42	$75.15 ▼ $115.00	$6.88B	0.38	180 shs	N/A
TLRY Tilray	$1.97 -0.3%	$2.00	$1.50 ▼ $3.40	$1.53B	2.36	30.52 million shs	593,313 shs
USNA USANA Health Sciences	$46.32 +2.9%	$46.38	$41.45 ▼ $69.60	$889.34M	0.94	81,320 shs	71,519 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
APHA Aphria	0.00%	0.00%	0.00%	0.00%	0.00%
CRON Cronos Group	+10.47%	+7.14%	+6.74%	+28.96%	+51.60%
STDAF STADA Arzneimittel Aktiengesellschaft	0.00%	0.00%	0.00%	0.00%	0.00%
TLRY Tilray	+1.54%	-1.98%	-3.65%	+5.32%	-28.00%
USNA USANA Health Sciences	+2.77%	-1.66%	-2.05%	-9.05%	-28.89%

The Crypto 9-5 Escape Plan (Ad)

A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.

Click here to get instant access to the guide

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
APHA Aphria	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	0.3956 of 5 stars	1.2	3.0	0.0	0.0	2.3	0.0	1.3
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	1.0625 of 5 stars	3.1	1.0	0.0	0.0	1.9	0.0	1.3
USNA USANA Health Sciences	3.2936 of 5 stars	1.3	3.0	0.0	3.0	2.5	1.7	2.5

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
APHA Aphria	N/A	N/A	N/A	N/A
CRON Cronos Group	2.33	Hold	$2.83	-1.62% Downside
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A
TLRY Tilray	2.25	Hold	$2.71	37.14% Upside
USNA USANA Health Sciences	2.50	Moderate Buy	$46.00	-0.69% Downside

Current Analyst Ratings

Latest STDAF, APHA, CRON, TLRY, and USNA Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/7/2024	USNA USANA Health Sciences	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$48.00 ➝ $46.00
4/10/2024	TLRY Tilray	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy	$4.25 ➝ $4.00
4/10/2024	TLRY Tilray	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$2.25 ➝ $2.00
4/8/2024	CRON Cronos Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$2.00 ➝ $2.50
4/5/2024	TLRY Tilray	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral	$2.25 ➝ $2.75
2/22/2024	USNA USANA Health Sciences	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$53.00 ➝ $48.00

(Data available from 5/10/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
APHA Aphria	$405.96M	12.00	$0.09 per share	166.43	$4.80 per share	3.20
CRON Cronos Group	$87.24M	12.61	N/A	N/A	$2.87 per share	1.00
STDAF STADA Arzneimittel Aktiengesellschaft	$3.84B	1.79	$11.12 per share	9.93	$23.11 per share	4.78
TLRY Tilray	$210.48M	7.26	N/A	N/A	$5.07 per share	0.39
USNA USANA Health Sciences	$921.01M	0.97	$4.48 per share	10.35	$25.99 per share	1.78

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
APHA Aphria	-$63.21M	-$0.06	N/A	219.71	N/A	-36.10%	-2.30%	-1.66%	N/A
CRON Cronos Group	-$73.96M	-$0.19	N/A	96.00	N/A	-84.15%	-3.99%	-3.87%	8/13/2024 (Estimated)
STDAF STADA Arzneimittel Aktiengesellschaft	$292.15M	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	-$1.45B	-$0.44	N/A	N/A	N/A	-43.98%	-2.68%	-2.09%	7/24/2024 (Estimated)
USNA USANA Health Sciences	$63.79M	$3.21	14.43	14.80	1.38	6.88%	12.80%	10.05%	7/23/2024 (Estimated)

Latest STDAF, APHA, CRON, TLRY, and USNA Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/29/2024	Q4 2023	CRON Cronos Group	N/A	-$0.05	-$0.05	$0.02	$25.15 million	$23.92 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
APHA Aphria	N/A	N/A	N/A	N/A	N/A
CRON Cronos Group	N/A	N/A	N/A	N/A	N/A
STDAF STADA Arzneimittel Aktiengesellschaft	N/A	N/A	N/A	N/A	N/A
TLRY Tilray	N/A	N/A	N/A	N/A	N/A
USNA USANA Health Sciences	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
APHA Aphria	0.25	2.36	1.17
CRON Cronos Group	N/A	22.54	21.81
STDAF STADA Arzneimittel Aktiengesellschaft	2.23	1.54	0.99
TLRY Tilray	0.11	1.92	1.18
USNA USANA Health Sciences	N/A	3.74	3.20

Ownership

Institutional Ownership

Company	Institutional Ownership
APHA Aphria	10.30%
CRON Cronos Group	8.71%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	9.35%
USNA USANA Health Sciences	54.25%

Insider Ownership

Company	Insider Ownership
APHA Aphria	N/A
CRON Cronos Group	1.96%
STDAF STADA Arzneimittel Aktiengesellschaft	N/A
TLRY Tilray	0.68%
USNA USANA Health Sciences	0.33%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
APHA Aphria	1,200	316.80 million	N/A	Optionable
CRON Cronos Group	356	382.01 million	374.52 million	Optionable
STDAF STADA Arzneimittel Aktiengesellschaft	12,500	62.34 million	N/A	Not Optionable
TLRY Tilray	1,600	774.03 million	768.77 million	Optionable
USNA USANA Health Sciences	1,800	19.20 million	19.14 million	Optionable

STDAF, APHA, CRON, TLRY, and USNA Headlines

Source	Headline
	DA Davidson Research Analysts Boost Earnings Estimates for USANA Health Sciences, Inc. (NYSE:USNA) americanbankingnews.com - May 10 at 3:14 AM
	DA Davidson Weighs in on USANA Health Sciences, Inc.'s FY2024 Earnings (NYSE:USNA) marketbeat.com - May 9 at 7:13 AM
	USANA Health Sciences (NYSE:USNA) Price Target Cut to $46.00 americanbankingnews.com - May 9 at 1:58 AM
	Research Analysts Offer Predictions for USANA Health Sciences, Inc.'s Q2 2024 Earnings (NYSE:USNA) americanbankingnews.com - May 9 at 1:22 AM
	Usana Health Sciences Chief Financial Officer Sold $232K In Company Stock benzinga.com - May 8 at 5:39 PM
	Insider Sale: CFO G Iiekking Sells Shares of Usana Health Sciences Inc (USNA) finance.yahoo.com - May 8 at 6:57 AM
	Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Director Sells $21,849.10 in Stock insidertrades.com - May 8 at 6:54 AM
	USANA Health Sciences, Inc. (NYSE:USNA) Forecasted to Post Q2 2024 Earnings of $0.68 Per Share marketbeat.com - May 8 at 6:29 AM
	USANA Health Sciences, Inc. (NYSE:USNA) CFO G Doug Iiekking Sells 5,198 Shares insidertrades.com - May 8 at 6:18 AM
	Insider Unloading: Daniel Macuga Sells $178K Worth Of Usana Health Sciences Shares benzinga.com - May 7 at 3:56 PM
	USANA Health Sciences (NYSE:USNA) PT Lowered to $46.00 marketbeat.com - May 7 at 11:51 AM
	Daniel A. Macuga Sells 3,791 Shares of USANA Health Sciences, Inc. (NYSE:USNA) Stock insidertrades.com - May 4 at 5:18 AM
	USANA Executive Chairman Kevin Guest Advocates for Family Wellness in May's Celebratory Month prnewswire.com - May 3 at 7:17 AM
	USANA Health Sciences (NYSE:USNA) Shares Gap Up to $41.52 americanbankingnews.com - May 3 at 6:08 AM
	Q2 2024 EPS Estimates for USANA Health Sciences, Inc. (NYSE:USNA) Lowered by Sidoti Csr americanbankingnews.com - May 3 at 1:58 AM
	USANA Health Sciences, Inc. (NYSE:USNA) Insider Sells $178,707.74 in Stock marketbeat.com - May 2 at 7:32 PM
	USNA or STVN: Which Is the Better Value Stock Right Now? zacks.com - May 2 at 12:41 PM
	Usana Health Sciences Inc (USNA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... finance.yahoo.com - May 2 at 8:15 AM
	USANA Health Sciences First Quarter 2024 Earnings: EPS Beats Expectations finance.yahoo.com - May 2 at 8:15 AM
	Sidoti Csr Brokers Reduce Earnings Estimates for USANA Health Sciences, Inc. (NYSE:USNA) marketbeat.com - May 2 at 7:34 AM
	Q1 2024 USANA Health Sciences Inc Earnings Call finance.yahoo.com - May 2 at 1:49 AM
	Q1 2024 USANA Health Sciences Inc Earnings Call Transcript gurufocus.com - May 2 at 1:01 AM
	USANA (USNA) Stock Trades Up, Here Is Why finance.yahoo.com - May 1 at 3:48 PM
	USNA Stock Earnings: Usana Health Sciences Beats EPS, Beats Revenue for Q1 2024 markets.businessinsider.com - April 30 at 11:39 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Stocks Leading the U.S. Agriculture Comeback
April 26, 2024 10:10 AM
View 3 Stocks Leading the U.S. Agriculture Comeback
How to Use Put Debit Spreads to Profit From Falling Stocks
April 26, 2024 9:30 AM
View How to Use Put Debit Spreads to Profit From Falling Stocks
MU Nears Breakout as Analysts Continue to Pound the Table
May 8, 2024 7:11 AM
View MU Nears Breakout as Analysts Continue to Pound the Table
Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
April 10, 2024 10:42 AM
View Heat Alert: Micron Just Got Named A Must-Own Stock for Q2
Cannabis Stocks: Game-Changing Catalyst for the Sector?
May 3, 2024 7:00 AM
View Cannabis Stocks: Game-Changing Catalyst for the Sector?

All Headlines

Company Descriptions

Aphria

NASDAQ:APHA

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.

Cronos Group

NASDAQ:CRON

Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

STADA Arzneimittel Aktiengesellschaft

OTCMKTS:STDAF

STADA is a publicly traded, international company with a focus on the healthcare market, especially the pharmaceutical and in particular the generics market.

Tilray

NASDAQ:TLRY

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Nanaimo, Canada.

USANA Health Sciences

NYSE:USNA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial